Table 2 Anti-CCP seropositivity of studied groups
From: Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
| Â | PsA (n = 40) | Psoriasis without arthritis (n = 40) | RA (n = 40) | Healthy controls (n = 40) | P-value |
|---|---|---|---|---|---|
Anti-CCP | Â | Â | Â | Â | Â |
-negative n (%) | 33 (82.5%) | 40 (100%) | 6 (15%) | 40 (100%) | <0.001 |
-positive n (%) | 7 (17.5%) | 0 | 34 (85%) | 0 | Â |